Samuel So
Publications
- Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol Imaging. 2012 Jul-Aug; (4): 363-72
- Low levels of knowledge and preventive practices regarding vertical hepatitis B transmission among perinatal nurses. J Obstet Gynecol Neonatal Nurs. 2012 Jul-Aug; (4): 494-505
- A model program for hepatitis B vaccination and education of schoolchildren in rural China. Int J Public Health. 2012; (3): 581-8
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012; (17): 6662-7
- Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One. 2011; (2): e16636
- Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces (Providence). 2011; (3): 289-300
- In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed. 2011; (5): 506-13
- San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer. J Community Health. 2011; (4): 538-51
- Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer. 2011: 16
- Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia. 2011; (8): 735-47
- Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. J Fam Pract. 2010; (4 Suppl): S37-42
- Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology. 2010; (2): 405-14
- Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians. Cancer Epidemiol Biomarkers Prev. 2010; (12): 3106-18
- Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health. 2010: 98
- Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Int J Cancer. 2010; (10): 2426-36
- Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: a call to action. Asian Pac J Cancer Prev. 2009 Jul-Sep; (3): 507-12
- Stopping a silent killer in the underserved asian and pacific islander community: a chronic hepatitis B and liver cancer prevention clinic by medical students. Asian Pac J Cancer Prev. 2009 Jul-Sep; (3): 383-6
- 3 For Life: a model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans. Am J Health Promot. 2009 Jan-Feb; (3): 176-81
- Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer. 2009: 76
- Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Gastroenterology. 2009; (1): 176-87
- Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. Anticancer Res. 2009; (10): 4083-92
- The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health. 2009; (4): 281-90
- Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2008 Oct-Dec; (4): 605-13
- Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Biomark Insights. 2008: 1-18
- N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett. 2008; (1): 133-42
- Phase II study of imatinib in unresectable hepatocellular carcinoma. Am J Clin Oncol. 2008; (1): 84-8
- Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Mol Cancer. 2008: 19
- Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2007 Jan-Mar; (1): 127-34
- Building partnerships with traditional chinese medicine practitioners to increase hepatitis B awareness and prevention. J Altern Complement Med. 2007; (10): 1125-7
- Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007; (7): 460-9
- Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol. 2007; (1): 76-83
- Re: "Ten largest racial and ethnic health disparities in the United States based on Healthy People 2010 objectives". Am J Epidemiol. 2007; (9): 1105-6; author reply 1106-7
- The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007; (10): 2100-8
- Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007; (4): 1034-40
- Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res. 2006 May-Jun; (3A): 1739-43
- Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol. 2006; (6): 854-63
- Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res. 2006; (4): 2048-58
- Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res. 2006; (1): 232-41
- An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene. 2005; (23): 3737-47
- Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis. 2005; (12): 2050-7
- Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res. 2005; (2 Pt 1): 551-6
- Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. J Vasc Interv Radiol. 2005; (11): 1473-8
- Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer. 2005: 29
- Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer. 2005; (1): 119-25
- Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. Neoplasia. 2005; (2): 91-8
- Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology. 2004; (2): 457-69
- Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res. 2004; (22): 7629-36
- Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol. 2004; (10): 1198-210
- Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene. 2003; (44): 6946-53
- One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation. 2003; (10): 1458-63
- Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003; (8): 3208-15
- Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene. 2002; (42): 6549-56
- Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts. Transplantation. 2002; (3): 465-9
- Gene expression patterns in human liver cancers. Mol Biol Cell. 2002; (6): 1929-39
- Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res. 2002; (16): 4711-21
- Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A. 2002; (25): 16203-8
- Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol. 2002; (3): 127-31
- CMV and EBV-PTLD after liver transplantation. Transplant Proc. 2001 Feb-Mar; (1-2): 1317-9
- Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. Transplant Proc. 2001 Feb-Mar; (1-2): 1490-1
- Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol. 2001; (6): 1339-45
- A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. Arch Surg. 2000; (9): 1063-8; discussion 1068-9
- Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol. 2000; (1): 69-73
- Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Liver Transpl. 2000; (1): 62-6
- Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? J Gastroenterol Hepatol. 1999: S48-52
- Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg. 1999; (1): 25-9
- Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant. 1999; (1): 22-6
- Major hepatic resection without blood transfusion: experience with total vascular exclusion. J Gastroenterol Hepatol. 1999: S28-31
- Resection versus transplantation for hepatocellular carcinoma. J Gastroenterol Hepatol. 1999: S37-41
- Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg. 1998; (3): 208-14
- Current status of living-related liver transplantation. Pediatr Transplant. 1998; (1): 16-25
- Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation. 1998; (1): 77-82
- Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Transplant Proc. 1998; (8): 4322-4
- Indications for pediatric liver transplantation. Pediatr Transplant. 1998; (2): 106-16
- Liver transplantation at Stanford University Medical Center. Clin Transpl. 1998: 287-96
- Liver transplantation in the first three months of life. Transplantation. 1998; (5): 606-9
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998; (7): 956-62
- Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. Transplantation. 1998; (7): 851-6
- Orthotopic liver transplantation from non-heart-beating donor rats: effect of flushing with cold/warm UW/SLS preservation solutions. Transplant Proc. 1997 Feb-Mar; (1-2): 1371-3
- Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: a case report. J Pediatr Surg. 1997; (1): 125-7
- Factors affecting survival after orthotopic liver transplantation in infants. Transplantation. 1997; (2): 242-8
- Liver transplantation in Asian patients with chronic hepatitis B. Hepatology. 1997; (1): 223-5
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg. 1997; (6): 628-37
- Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. Dig Dis Sci. 1997; (7): 1409-15
- Superior outcomes in pediatric renal transplantation. Arch Surg. 1997; (8): 842-7; discussion 847-9
- Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy. J Pediatr Gastroenterol Nutr. 1997; (4): 421-5
- Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation. Transplantation. 1996; (1): 130-2
- Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. Transplant Proc. 1996; (3): 1381-2
- Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. Transplantation. 1996; (8): 1188-92
- Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg. 1996; (9): 935-9; discussion 939-41
- Primary liver transplantation without transfusion of red blood cells. Surgery. 1996; (4): 698-704; discussion 704-5
- Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. Transplantation. 1996; (5): 847-8
- A reassessment of ABO incompatibility in pediatric liver transplantation. Transplantation. 1995; (7): 757-60
- Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation. 1995; (1): 97-102
- An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 1995; (4): 524-9
- Characterization of cytokine expression in an animal model of acute liver allograft rejection. Transplant Proc. 1995; (1): 505-6
- Circulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in pediatric liver recipients. Transplant Proc. 1995; (1): 1148-9
- Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation. 1995; (4): 584-9
- Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. Transplant Proc. 1995; (1): 1146-7
- Effects of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation. Hepatology. 1995; (4): 1079-82
- Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation. 1995; (12): 1533-8
- FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. Clin Transplant. 1995; (1): 45-52
- Fulminant hepatic failure following varicella-zoster infection in a child. A case report of successful treatment with liver transplantation and perioperative acyclovir. Transplantation. 1995; (9): 1052-3
- Impact of reduced-size liver transplantation on rejection and liver allograft outcome in the pediatric population. Transplant Proc. 1995; (1): 1239-40
- Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. Transplantation. 1995; (5): 791-3
- Liver transplantation in a child with sickle cell anemia. Transplantation. 1995; (10): 1490-2
- Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Transplant Proc. 1995; (1): 241-2
- Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Transplant Proc. 1995; (1): 1211-2
- The use of non-heart-beating cadaver donors in experimental liver transplantation. Transplantation. 1995; (10): 1179-80
- Aggressive early cyclosporine therapy is desirable in pediatric renal transplantation. Transplant Proc. 1994; (1): 88-90
- Ex vivo technique for right lobectomy in pediatric hepatic transplantation. J Am Coll Surg. 1994; (5): 601-3
- FK506 conversion therapy in pediatric liver transplantation. Transplantation. 1994; (8): 1169-73
- Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial. Transplantation. 1994; (3): 377-84
- Liver transplantation at California Pacific Medical Center, San Francisco, California. Clin Transpl. 1994: 163-71
- Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation. 1994; (4): 447-50
- Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents. Transplantation. 1994; (4): 540-4
- Respiratory distress from benign liver tumors: a report of two unusual cases treated with hepatic transplantation. J Pediatr Gastroenterol Nutr. 1994; (1): 114-7
- Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation. Transplant Proc. 1993; (6): 3196-8
- Cytomegalovirus prophylaxis in pediatric renal transplant recipients. Transplant Proc. 1993; (1 Pt 2): 1414-5
- FK 506 rescue therapy: early conversion improves efficacy. Transplant Proc. 1993; (2): 1990-1
- FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. Transplant Proc. 1993; (2): 1992-3
- Intrahepatic portosystemic vascular stents: a bridge to hepatic transplantation. Surgery. 1993; (3): 344-51
- Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Transplant Proc. 1993; (6): 3025-6
- Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. Transplant Proc. 1993; (2): 1988-9
- Successful retransplantation after a 48-hour anhepatic state. Transplant Proc. 1993; (2): 1962-3
- Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis. J Pediatr. 1992; (4 Pt 1): 575-8
- FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Transplantation. 1992; (2): 377-81
- QT prolongation and Torsades de Pointes after administration of FK506. Transplantation. 1992; (4): 929-30
- A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients. Transplant Proc. 1991; (1 Pt 2): 1050-1
- Anesthetic management of infants receiving an adult kidney transplant. Anesth Analg. 1991; (6): 725-30
- FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. Transplant Proc. 1991; (6): 2992-3
- Laparoscopic drainage of a posttransplant lymphocele. Transplantation. 1991; (3): 725-7
- Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Transplantation. 1991; (5): 805-10
- Short-term and long-term effects of HLA matching in cadaveric pancreas transplantation. Transplant Proc. 1991; (1 Pt 2): 1634-6
- Significance of B-cell crossmatch on outcome in renal transplantation. Transplant Proc. 1991; (1 Pt 1): 434-6
- Successful kidney transplantation in infants. Transplant Proc. 1991; (1 Pt 2): 1382-3
- Reversible hepatic transplant ischemia: case report and review of literature. Cardiovasc Intervent Radiol. 1990 Apr-May; (2): 88-90
- DR matching improves cadaveric pancreas transplant results. Transplant Proc. 1990; (2): 687-8
- Renal transplantation in infants. Ann Surg. 1990; (3): 353-65; discussion 366-7
- The use of cadaver kidneys for transplantation in young children. Transplantation. 1990; (6): 979-83
- Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes. Transplantation. 1989; (1): 163-70
- In vitro immunosuppressive effects of murine hepatocyte cytosol. Transplant Proc. 1989; (1 Pt 1): 1154-5
- A comparison of three immunosuppressive protocols in patients aged over 50 years. Transplant Proc. 1987; (1 Pt 2): 1530-1
- Class I major histocompatibility complex antigens are induced on hepatocytes in rejecting human liver grafts. Transplant Proc. 1987; (1 Pt 3): 2464-5
- Dialysis access: radiographic evaluation and management. Radiol Clin North Am. 1987; (2): 249-60
- First kidney transplants in children 5 years of age or younger. Transplant Proc. 1987; (1 Pt 3): 2111-2
- Growth and development in infants after renal transplantation. J Pediatr. 1987; (3): 343-50
- Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation. 1987; (1): 79-85
- Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation. J Pediatr. 1987; (6 Pt 2): 1017-21
- Major histocompatibility complex class I antigens on hepatocytes in human liver grafts. Transplant Proc. 1987; (4 Suppl 3): 66-7
- Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. Transplant Proc. 1987; (1 Pt 1): 251-2
- Renal transplantation at the University of Minnesota during the 1980s. Clin Transpl. 1987: 167-81
- Preliminary results of low-dose cyclosporin A in pediatric renal transplantation. Int J Pediatr Nephrol. 1986 Apr-Jun; (2): 91-4
- Current results in pediatric renal transplantation at the University of Minnesota. Kidney Int Suppl. 1986: S25-30
- The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg. 1986; (3): 246-58
- Improved results of multiple renal transplantation in children. Surgery. 1985; (4): 729-38
- Thrombosed synthetic hemodialysis access fistulas: failure of fibrinolytic therapy. Radiology. 1985; (3): 639-42
- Hickman catheter for pediatric hemodialysis: a 3-year experience. Trans Am Soc Artif Intern Organs. 1984: 619-23
- Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation. 1984; (6): 619-24
- Bile ascites during infancy: diagnosis using Disofenin Tc 99m sequential scintiphotography. Pediatrics. 1983; (3): 402-5
- Failing or thrombosed Brescia-Cimino arteriovenous dialysis fistulas. Angiographic evaluation and percutaneous transluminal angioplasty. Radiology. 1983; (1): 105-9
- HBV markers in Chinese in Hong Kong. Ann Acad Med Singapore. 1980; (2): 149-51
- The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma. J Surg Oncol. 1977; (6): 527-40
Help
Trial Administration